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Abstract The 3P processing of M1 RNA, the catalytic com-
ponent of Escherichia coli RNase P, occurs by two pathways
involving multiple steps. The precursor of M1 RNA has an rne-
dependent site downstream of the processing site, whose sequence
variation affects the processing efficiency. In this study, we
showed that the sequence itself of the rne-dependent site
possessed the ability to determine the processing pathways and
that it also affected the cleavage specificity with the generation
of the processing products at one nucleotide upstream or
downstream of the normal cleavage sites. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
M1 RNA is the RNA component of Escherichia coli RNase
P that endonucleolytically removes 5P leader sequences from
precursors of tRNAs, generating the mature 5P-ends of
tRNAs [1,2]. M1 RNA of 377 nucleotides forms by 3P pro-
cessing of a major primary transcript of the rnpB gene, pre-
cursor M1 RNA (pM1 RNA) of 413 nucleotides [3^8].
Although RNase E is involved in the 3P processing of M1
RNA [6^8], other enzymes seem to be required for the com-
plete maturation of M1 RNA at the 3P-end [9]. An in vitro
analysis of the processing also showed the presence of the
+385/+386 RNA intermediates which are further processed
to +378/+379 RNA by another processing activity [10]. Since
the +378/+379 RNA can be generated in vitro with an endo-
nucleolytic cleavage that is believed to be carried out by
RNase E, it was suggested that there are at least two path-
ways for the 3P processing of M1 RNA. Finally, the mature
3P-end of +377 should be generated from +378/+379 RNA
products in vivo through cleavage of the extra nucleotides
by exoribonucleases [9,10].
pM1 RNA has a pentanucleotide of GAUUU, immediately
3P to the processing site [8]. This pentanucleotide accords with
the consensus sequence, [A/G]AUU[A/U], of the the rne-de-
pendent site [11]. The sequence of the rne-dependent site is
thought to be recognized and cleaved by RNase E [11],
although the primary sequence alone of the rne-dependent
site was insu⁄cient to account for the cleavage speci¢city by
RNase E in some cases [12,13]. The rne-dependent site has
been reported to be located in a single-stranded region that is
rich in U and A nucleotides [14^16]. Although the rne-depen-
dent site of pM1 RNA is the major factor for determining the
processing e⁄ciency [8], essentially nothing is known about
the mechanism by which its sequence would a¡ect the pro-
cessing e⁄ciency. This is because 3P processing of M1 RNA is
not a simple process, but a complex one that occurs through
two pathways with multiple steps that require many enzymes
[10].
In this study, we examined the e¡ect of the sequence of the
rne-dependent site on the pathways of 3P processing of M1
RNA. We showed that the primary sequence itself of the rne-
dependent site possessed the ability to determine the process-
ing pathways. Therefore, the sequence of the rne-dependent
site seems not only to a¡ect the processing e⁄ciency, but also
to guide the RNA metabolic pathway. Our results may pro-
vide a mechanistic basis for the role of the rne-dependent site
in control of biosynthesis of M1 RNA in E. coli.
2. Materials and methods
2.1. Bacterial strains and plasmids
E. coli JM109 [17] was used for the construction of plasmids and
the preparation of cell extract. The plasmid vectors used were pGEM3
and pALTER-1 from Promega. Plasmid pMTd23 [8] is a derivative of
pGEM3, which contains the rnpB transcription unit with an internal
deletion of the sequence between +57 and +330. Plasmid pSPd23 [8] is
a derivative of pMTd23, but it carries the SP6 promoter linked to the
5P-end of the M1 RNA-encoding sequence, and a DraI site at position
+415. pSP^RNE series [8] are derivatives of pSPd23 carrying muta-
tions at the rne-dependent site; pMT^RNE series [8] are derivatives of
pMTd23 carrying the same mutations at the rne-dependent site as the
corresponding pSP^RNE series.
2.2. Site-directed mutagenesis
Site-directed mutagenesis was carried out according to the Prome-
ga-Altered System protocol to generate ¢ve more mutations at the
rne-dependent site. The mutations were introduced to generate
DNA templates for in vitro transcriptions of RNA having changed
sequences between positions +378 and +382 (Fig. 1). Plasmid pSPd23
was used for mutagenesis. Oligonucleotides used for constructing the
following mutant plasmids were as follows: pSP-RNE (GCCCU):
5P-GCGGGTTTTTACGTAGGGCAGGTGAAACTGACC-3P ; pSP-
RNE (GCCUU): 5P-CGGGTTTTTACGTAAGGCAGGTGAAA-
CTGACC-3P ; pSP-RNE (GCUUU): 5P-TTTACGTAAAGCAGGT-
GAAAC-3P ; pSP-RNE (GUUUU):5P-TTTACGTAAAACAGGT-
GAAAC-3P ; pSP-RNE (UUUUU): 5P-GGGTTTTTACGTAAAAA-
AGGTGAAACTGACCG-3P. The mutated bases are shown in bold.
All mutations generated by the mutagenesis were veri¢ed by DNA
sequencing.
The 129-bp EcoRI^BamHI DNA fragments of these pSP-RNE
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plasmids were moved to plasmid pMTd23/EcoRI^BamHI to yield the
corresponding pMT^RNE series which had the rnpB transcription
unit.
The DNA templates for transcripts having the 3P-end of +386 were
constructed by polymerase chain reaction (PCR) from pSP-RNE plas-
mids with a pair of primers SP and RSA; SP and RSA were previ-
ously described [10]. The PCR products were cloned into the pGEM-
Teasy vector (Promega).
2.3. In vitro transcription of substrates
For in vitro transcription of RNA substrates to be used for the in
vitro processing assay, plasmid DNAs were cleaved with DraI for the
RNA end of +415 of RsaI for that of +386, and used as templates for
run-o¡ transcription by SP6 RNA polymerase. In vitro transcription
products were puri¢ed by gel elution, as described [18].
In vitro transcripts were labeled at the 3P-end with [32P]pCp and T4
RNA ligase, or internally with [K-32P]CTP, as described [18].
2.4. Northern hybridization
Total cellular RNAs from E. coli cells containing pMT^RNE series
were prepared, as previously described [8]. RNAs were electrophores-
ed in a 5% polyacrylamide gel containing 7 M urea, electrotransferred
to a nylon membrane (Hybond N+; Amersham) with a Hoefer Semi-
Phor Semi-dry transfer unit, and then they were hybridized, as de-
scribed [8]. The probe used was 32P-labeled antisense M1 RNA pre-
pared, as described [8].
2.5. In vitro processing assay
The 40% ammonium sulfate precipitation (ASP-40) was prepared
from E. coli JM109 and used in vitro processing assay, as described
[8]. The yeast total RNA of 0.7 mg/ml was added into the reaction
mixture when required. RNA substrates were incubated at 37‡C with
ASP-40. The reaction products were analyzed by electrophoresis on a
polyacrylamide sequencing gel containing 8 M urea.
3. Results and discussion
3.1. Changes of the processing pathway by the sequence
variation at the rne-dependent site
Since 3P processing of M1 RNA occurs through two path-
ways (Fig. 1; [10]), we determined whether the rne-dependent
site would govern the pathway choice or not. We used p23
RNA (Fig. 1B) as a model substrate, a truncated M1 RNA
which was generated from the rnpB gene with a deletion in
the M1 RNA-structural gene [8,10]. The rne-dependent site
mutants were previously constructed with random nucleotides
di¡ering from the consensus sequence of the rne-dependent
site, and it was shown that all of the random mutants were
processed less e⁄ciently than the wild-type in vivo ([8], see
also Table 1). The choice of the pathways was examined in
the in vitro processing reaction using the ASP-40 as a partially
puri¢ed cell extract in the absence or presence of excess yeast
total RNA. Since the ASP-40 fraction lacks a processing ac-
tivity responsible for the trimming of one or two nucleotides
at the 3P-end of +378/+379 RNA intermediates, the ¢nal in
vitro processing products are +378/+379 RNA. When excess
yeast total RNA in included in the in vitro reactions, +385/
+386 intermediates are accumulated because excess yeast total
RNA blocks the second step of pathway I (Fig. 1; [10]). The
time-course experiment has shown that these intermediates are
processed to the ¢nal products [10]. Therefore, the appearance
of the +385/+386 RNA intermediates in the in vitro reaction
with excess yeast total RNA represents that the processing
Fig. 1. A: Proposed model of 3P processing pathways of M1 RNA
[10]. Pathway I is involving the +385/+386 RNA intermediates, and
pathway II is not. The ¢nal trimming step of one or two nucleotides
from +378/+379 RNA to generate the mature M1 RNA with the
3P-end of +377 is also represented. B: A possible secondary struc-
ture of p23 RNA, a truncated pM1 RNA transcribed from the in-
ternally deleted rnpB gene is shown. The arrowhead indicates the
3P-end of the mature M1 RNA. The rne-dependent site is under-
lined.
Table 1
E¡ects of the sequence variations at the rne-dependent site on the
processing of p23 RNA
Sequence Relative processing e⁄ciencya
GAUUU (WT) 1.00
CGCCC 0.13b
CCCCA 0.09b
GCCAG 0.13b
GCCAC 0.14b
AUCAU 0.80b
UCACU 0.36b
UUCGG 0.47b
UUCAU 0.54b
GCCCU 0.14
GCCUU 0.39
GCUUU 0.79
GUUUU 0.94
UUUUU 1.00
aThe processing e⁄ciency was calculated as a ratio of the amount
of the processed RNA (23 RNA) to that of the total transcripts
(p23 RNA+23 RNA). The relative processing e⁄ciency represents
the processing e⁄ciency of a derivative relation to that of the wild-
type (WT).
bThe values from Kim et al. [8]
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occurs by pathway I. On the other hand, the appearance of
the +378/+379 RNA in the presence of excess yeast total
RNA reveals that the processing occurs by pathway II.
DNA templates for generating p23 RNA substrates were
originally designed in such a way that in vitro transcription
by SP6 RNA polymerase was initiated at the ¢rst nucleotide
of M1 RNA, and this, in turn, generated run-o¡ transcripts
having the 3P-end of +415 when cleaved with DraI. However,
SP6 RNA polymerase also terminates at the rnpB T1 termi-
nator to generate a shorter transcript having the 3P-end of
+413 ([10]; Sim and Lee, unpublished results). Since the
3P-end of pM1 RNA is +413, p23 RNA having the 3P-end
of +413 was puri¢ed from the gel and used as a substrate.
Fig. 2A showed that the sequence of the rne-dependent site
a¡ected the formation of +385/+386 RNA intermediates, in-
dicating that the pathways are determined by the sequence of
the rne-dependent site. The rne-dependent site variants can be
categorized according to their preference for the processing
pathway (Fig. 3). Group I variants are processed only through
pathway I. Group II variants are processed only through
Fig. 2. In vitro processing of mutant p23 RNAs having changes at the rne-dependent site. Substrate RNAs were transcribed in vitro with
[K-32P]CTP. Synthetic transcripts were incubated at 37‡C for 10 min with a partially puri¢ed cell extract (ASP-40) from JM109. The reaction
products were resolved on a 5% polyacrylamide sequencing gel containing 8 M urea. The following substrates were used for the analysis:
(A) p23 RNA variants of random mutations at the rne-dependent site, (B) p23 RNA variants of U-mutations, (C) +386 intermediates of the
U-variants. The mutated sequences at the rne-dependent site are indicated above each lane. The presence and absence of yeast total RNA are
indicated with a + or 3. W.T. indicates the wild-type.
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pathway II. Both pathways operate for the processing of
group III variants. As well as the wild-type, p23 RNA var-
iants bearing AUCAU, UCACU, UUCGG, and UUCAU
belong to group III. On the other hand, p23 RNA variants
of GCCAG, GCCAC, CGCCC, and CCCCA belong to
group I. The G/C contents in the pentanucleotide sequence
of the rne-dependent site seemed to be responsible for the
pathway preference because p23 RNA variants rich in G/C
nucleotides preferred to be processed by pathway I.
For the more systematic study of the in£uence of G/C con-
tents, we constructed ¢ve U-variants by changing the U con-
tent from GCCCU, to GCCUU, GCUUU, GUUUU, and
UUUUU. The more U nucleotides that were present in the
rne-dependent site, the better the processing e⁄ciency in vivo
(Fig. 4 and Table 1), which is in accord with the previous
result of the U preference for the e⁄cient processing [8].
The in vitro processing of the ¢ve U-variants was assayed
(Fig. 2B). The processing patterns of the ¢ve U-variants
(Figs. 2 and 3) showed that the variants carrying high G/C
content in the rne-dependent site preferred the processing by
pathway I to that by pathway II. One extreme was the
GCCCU variant which was processed only by pathway I.
The opposite extreme was the UUUUU variant which was
processed only by pathway II. Compared with the U-variants,
the wild-type of GAUUU had high e⁄ciencies and was pro-
cessed by both pathways (Table 1 and Fig. 3). Therefore, it is
likely that the wild-type sequence provides a greater advan-
tage because it can provide one more regulatory site, which
may be needed for a ¢ner tuning of the maturation of M1
RNA. These ¢ndings imply that the sequence of the rne-de-
pendent site guides the RNA-metabolic pathway for regula-
tion of RNA-processing in E. coli.
One may argue that excess yeast total RNA might not in-
hibit further processing of +385/+386 RNA intermediates of
some variants, especially those of group II. However, Fig. 2C
shows that excess yeast total RNA inhibited further process-
ing of the +386 intermediates derived from all of the U-var-
iants. The products, which were generated from the +386
RNA of the UUUUU variant by ASP-40 in the absence of
excess yeast total RNA, were larger than the products from
the corresponding p23 RNA. Since the UUUUU variant of
p23 RNA did not generate the +385/+386 RNA intermediates
(Fig. 2B), the RNA products from the +386 RNA in Fig. 2C
could di¡er from the genuine processing products in the case
of the UUUUU variant.
It has not been clear why 3P processing of M1 RNA occurs
by two pathways. The two pathways may be independently
involved in regulation for producing the mature M1 RNA
within the cell, which consequently should in£uence biosyn-
thesis of RNase P. The fact that the wild-type rne-dependent
site is the most appropriate sequence for e⁄cient processing
by each pathway supports this possibility. The synthesis rate
of RNase P is expected to vary with growth conditions [19], as
do the translational apparati such as ribosomes and tRNA
[20,21]. The M1 RNA processing may play an important
role in growth-dependent regulation for the synthesis of
RNase P because there is some evidence that RNA processing
or degradation activities, including RNase E, are also regu-
lated by growth conditions [19,22^24]. Then each pathway of
3P processing of M1 RNA would di¡erentially contribute to
this regulation under di¡erent growth conditions.
3.2. Changes of the cleavage sites by the sequence variation at
the rne-dependent site
The sequence alterations at the rne-dependent site caused
the variations of product sizes in vitro (Fig. 2). Since the RNA
substrates were internally labeled, we examined whether or
not this size variation was due to di¡erent 3P-ends of the
products. The products were eluted from the gel and subjected
to primer extension analysis. The primer extension analysis
showed that all the products had the same 5P-ends (data not
shown). This result con¢rmed that the di¡erent size resulted
from the variation of the 3P-end. Although the in vivo 3P-end
of 23 RNA, the processing product of the wild-type p23
RNA, is +377, ASP-40 generates the +378/+379 products
having one or two nucleotides more than 23 RNA [10]. The
variants of GCUUU and GUUUU produced +378/+379
products that had the same 3P-ends with that of the wild-
type GAUUU. The variants of GCCCU and GCCUU, as
well as GCCAG, GCCAC, CGCCC, and CCCCA, generated
the processing products with the 3P-ends of +379/+380. On the
Fig. 3. Processing pathways deployed by the rne-dependent site var-
iants and their cleavage sites. Group I, II, and III variants are pro-
cessed only through pathway I, only through pathway II, and
through both pathways, respectively. Arrows indicate the cleavage
sites corresponding to the data in Figs. 2 and 5. The rne-dependent
sites are shown in bold capital letters.
Fig. 4. In vivo analysis of U-variants of the rne-dependent site. To-
tal cellular RNAs were prepared from 2U107 cells containing the
mutant plasmids of pMT^RNE series. The RNAs were separated
on a 5% polyacrylamide gel containing 7 M urea, and analyzed by
Northern blotting. The mutated sequences of the rne-dependent site
are indicated above each lane.
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other hand, the UUUUU variant, as well as the variants of
AUCAU, UCACU, UUCGG, and UUCAU, produced the
3P-ends of +377/+378.
When the rne-dependent site variants were listed according
to their cleavage sites (Fig. 3), the variants that produced the
+379/+380 ends had all G/C at the ¢rst three nucleotides of
the rne-dependent site, while the variants generating +377/
+378 products had A/U at the ¢rst nucleotide of the rne-de-
pendent site. Although we have not tested all possible varia-
tions, our results indicate that the position of speci¢c bases at
the rne-dependent site can determine in vitro cleavage sites by
either pathway I or II. This cleavage speci¢city may explain a
complicated relationship of sequence changes of the rne-de-
pendent site to the cleavage speci¢city, which was observed in
other RNA substrates [14,15].
To see whether di¡erent 3P-ends could be generated by an
endoribonucleolytic cleavage involved in pathway II, the 3P-
end-labeled substrates were used for the processing assay (Fig.
5). The variants of GCUUU, GUUUU, and UUUUU pro-
duced the downstream products corresponding to the up-
stream products formed by the endoribonucleolytic cleavage.
Therefore, the sequence at the rne-dependent site determined
the endonucleolytic cleavage sites of pathway II. In the case of
the variants of GCCCU and GCCUU, the corresponding
downstream cleavage products were not produced because it
was processed only by pathway I. Interestingly, all the var-
iants involving both pathways I and II for the processing
generated the same 3P-ends, suggesting that the 3P-end forma-
tion by pathway I is also a¡ected by the sequence at the rne-
dependent site. RNase E is responsible for the endoribonu-
cleolytic cleavage of pathway II by recognizing the rne-depen-
dent site [10]. The pathway I-dependent cleavage speci¢city
may also be related somehow to RNase E recognition.
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Fig. 5. Identi¢cation of downstream processing products. RNA sub-
strates labeled at 3P-end were incubated with ASP-40 and analyzed
on a 10% polyacrylamide sequencing gel. OH: Indicates alkaline hy-
drolysis ladders. G: Stands for G-speci¢c (RNase T1) cleavage
products.
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